Annual Reports

Annual Report for the year ended 30 June 2012

18 Oct 2012
Clinuvel's Annual Report for the year ended 30 June 2012.

Annual Report for the year ended 30 June 2011

Contents: INTRODUCTION ERYTHROPOIETIC PROTOPORPHYRIA (EPP) NONSEGMENTAL VITILIGO (NSV) CLINUVEL BUSINESS MODEL CORPORATE MILESTONES CHAIR's LETTER MANAGING DIRECTOR’S REPORT FINANCIALS ADDITIONAL INFORMATION REQUIRED BY THE ASX MARKET PERFORMANCE GLOSSARY

Annual Report for the year ended 30 June 2010

Annual Report for the year ended 30 June 2010.  

Annual Report for the year ended 30 June 2000

Annual Report for the year ended 30 June 2000.  

Annual Report for the year ended 30 June 2001

Annual Report for the year ended 30 June 2001  

Annual Report for the year ended 30 June 2002

Annual Report for the year ended 30 June 2002.  

Annual Report for the year ended 30 June 2003

Annual Report for the year ended 30 June 2003.  

Annual Report for the year ended 30 June 2004

Annual Report for the year ended 30 June 2004.  

Annual Report for the year ended 30 June 2005

Annual Report for the year ended 30 June 2005.  

Annual Report for the year ended 30 June 2006

Annual Report for the year ended 30 June 2006  
Page 1 of 2

Investors' Blog Posts

We've just released the first results from our vitiligo program which you can view online here. Following their release, we expect a number...

Read More

Clinuvel Non-Executive Director Brenda Shanahan has been honoured at The Australian Financial Review and Westpac Group Woman of Influence...

Read More

Since we publicly announced our vitiligo program in 2010, the entire Clinuvel team has aimed to gain a better understand this disease, its...

Read More

Related Webcasts

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Investor Spotlight